                               SEQUENCE LISTING

<110> CLEMSON UNIVERSITY
 
<120> CONOTOXIN PEPTIDES FOR USE IN BIOFOULING DETERRENCE

<130> CXU-869-PCT

<140> PCT/US2016/033275
<141> 2016-05-19

<150> 62/165,345
<151> 2015-05-22

<160> 14    

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxy proline 

<400> 1
Asn Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 2
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxy proline 

<400> 2
Val Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MISC_FEATURE
<222> (2)..(2)
<223> May or may not be present

<400> 3
Glu Asn Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10                  


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxy proline 

<220>
<223> C-term NH2

<400> 4
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<400> 5
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 6
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> D-cysteine 

<400> 6
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 7
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> 4-methoxy tyrosine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<400> 7
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 8
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> 4-methoxy tyrosine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> 4-hydroxyproline 

<400> 8
Glu Asn Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10                  


<210> 9
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> 4-hydroxyproline 

<400> 9
Glu Asn Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10                  


<210> 10
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<220>
<223> Free acid C terminal

<400> 10
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 11
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<220>
<223> Free acid C terminal

<400> 11
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 12
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate or D-pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxyproline 

<400> 12
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 13
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamate 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> 4-hydroxy proline 

<220>
<223> C-term NH2

<400> 13
Glu Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys 
1               5                   10              


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term COOH

<220>
<223> C-term modified by a functional group capable of 
      binding to a substrate surface

<400> 14
Gly Gly Gly Gly Gly Gly Gly 
1               5           


